showed that the administration of the SGLT2i empagliflozin for 4 weeks, (compared to a control group), reduced fat mass, leading to morphological changes in adipose tissue, specifically an increase in the number of small and medium-sized adipocytes and a reduction in the number of large adipocytes [82], an indirect sign of browning [25]
One meta-analysis involving patients with T2D without cardiovascular disease found a reduction in MACE associated with SGLT2i regimens of (adjusted pooled OR and 95% CI) 0.82 (0.730.92), with GLP1-RAs regimens of 0.93 (0.811.06), and with combined therapy of 0.70 (0.500.98)
While some patients choose to stay on maintenance doses of semaglutide for the rest of their lives, many are able to fully taper off after theyve hit their weight loss goalsand stay at that weight!so long as they follow a healthy diet and consistent exercise routine
The Role of Personalization in Your Weight Loss Journey At TrimRx, we understand that weight loss is not a one size fits all process